HomeVRAX • NASDAQ
add
Virax Biolabs Group Ltd
Previous close
$1.93
Day range
$1.93 - $1.93
Year range
$0.60 - $9.00
Market cap
7.86M USD
Avg Volume
9.49M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
CNBC
16 minutes ago
10 things to watch in the stock market Friday including a bullish call on
Best Buy
0.19%
1.50%
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 39.96K | 2,752.25% |
Operating expense | 1.72M | -19.83% |
Net income | -1.91M | 4.73% |
Net profit margin | -4.78K | 96.66% |
Earnings per share | — | — |
EBITDA | -1.67M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.67M | -61.00% |
Total assets | 5.48M | -44.11% |
Total liabilities | 345.19K | -62.00% |
Total equity | 5.14M | — |
Shares outstanding | 2.57M | — |
Price to book | 0.92 | — |
Return on assets | -77.50% | — |
Return on capital | -79.24% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -1.91M | 4.73% |
Cash from operations | -1.39M | -48.11% |
Cash from investing | -228.13K | -155.75% |
Cash from financing | 863.49K | -74.77% |
Net change in cash | -759.32K | -131.75% |
Free cash flow | -790.30K | -16.30% |
About
Founded
2013
Website
Employees
17
